DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,415 | -20.4% | 13,216 | 0.0% | 0.04% | -12.5% |
| Q2 2023 | $148,680 | -51.2% | 13,216 | -50.0% | 0.05% | -9.4% |
| Q1 2023 | $304,496 | +97.2% | 26,432 | +98.3% | 0.05% | -3.6% |
| Q4 2022 | $154,448 | -7.5% | 13,326 | +1.2% | 0.06% | -11.3% |
| Q3 2022 | $167,000 | +83.5% | 13,168 | -0.2% | 0.06% | +87.9% |
| Q2 2022 | $91,000 | -28.3% | 13,191 | 0.0% | 0.03% | -13.2% |
| Q1 2022 | $127,000 | -15.3% | 13,191 | +4.2% | 0.04% | -9.5% |
| Q4 2021 | $150,000 | -26.1% | 12,657 | +1.2% | 0.04% | -34.4% |
| Q3 2021 | $203,000 | -22.8% | 12,513 | 0.0% | 0.06% | -16.9% |
| Q2 2021 | $263,000 | +35.6% | 12,513 | 0.0% | 0.08% | +28.3% |
| Q1 2021 | $194,000 | – | 12,513 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |